ascopubs.org

Phase 2 trial of dual EGFR inhibition with cetuximab and afatinib in patients with recurrent/metastatic head and neck squamous cell cancers (HNSCC).

Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic nasal cavity and paranasal sinus squamous-cell carcinoma: A prospective phase ll study.
The Durango Herald

Durango School District’s SOIL Lab wraps second phase of development

Durango School District 9-R is celebrating the completion of phase 2 of its SOIL Outdoor Learning Lab and community garden at Riverview Elementary School in northeast Durango. Durango School District ...
ascopubs.org

Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker-based study (Alliance A032102).

Addition of darolutamide to first line treatment of metastatic castration-resistant prostate cancer (mCRPC): A randomized open label phase II trial (SAKK 08/23). This is an ASCO Meeting Abstract from ...
Nasdaq

Vigil Neuroscience Advances VG-3927 into Phase 2 Trial as a Promising Once-Daily Oral Therapy for Alzheimer's Disease Following Positive Phase 1 Results

Vigil Neuroscience, Inc. announced positive Phase 1 clinical trial results for VG-3927, a potential once-daily oral therapy for Alzheimer’s disease (AD). The trial demonstrated favorable safety, ...